Progenics Pharma (PGNX) – Analyst Ratings
-
BTIG Reiterates Buy Rating on Progenics Pharmaceuticals (PGNX)
-
Brookline Capital Markets Starts Progenics Pharmaceuticals (PGNX) at Buy
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PGNX Stock Lookup